ETFS Holding Sanofi

 
ETFS Holding Sanofi top ^
  • Holdings: Top Holdings EWQ More..., Sanofi, Total SA, BNP Paribas, Danone, LVMH Moet Hennessy Louis Vuitton SA
  • Category: Miscellaneous Region
Sign-up for ewq investment picks
  • Holdings: Top Holdings EZU More..., Sanofi, Total SA, Bayer AG, Siemens AG, Basf SE
  • Category: Europe Stock
  • Morningstar Rating: 1 Stars
Sign-up for ezu investment picks
  • Holdings: Top Holdings AXHE More..., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline PLC, Novo Nordisk A/S
  • Category: Health
Sign-up for axhe investment picks
  • Holdings: Top Holdings FEZ More..., Sanofi, Total SA, Bayer AG, Basf SE, Siemens AG
  • Category: Europe Stock
  • Morningstar Rating: 1 Stars
Sign-up for fez investment picks
  • Holdings: Top Holdings ADRU More..., HSBC Holdings PLC ADR, Novartis AG ADR, Vodafone Group PLC ADR, BP PLC ADR, Sanofi ADR
  • Category: Europe Stock
  • Morningstar Rating: 3 Stars
Sign-up for adru investment picks
  • Holdings: Top Holdings EFV More..., HSBC Holdings PLC, Novartis AG, Vodafone Group PLC, BP PLC, Sanofi
  • Category: Foreign Large Value
  • Morningstar Rating: 3 Stars
Sign-up for efv investment picks
  • Holdings: Top Holdings IRY More..., Novartis AG, Roche Holding AG, Sanofi, GlaxoSmithKline PLC, Bayer AG
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for iry investment picks
  • Holdings: Top Holdings HEDJ More..., Bayer AG, Daimler AG, Unilever NV DR, Anheuser-Busch Inbev SA, Sanofi
  • Category: Europe Stock
  • Morningstar Rating: 4 Stars
Sign-up for hedj investment picks
  • Holdings: Top Holdings PPH More..., Johnson & Johnson, Pfizer Inc, Novartis AG ADR, Merck & Co Inc, Sanofi ADR
  • Category: Health
Sign-up for pph investment picks

 
Stock Quotes for Sanofi top ^
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Mid Growth
Sign-up for eqsanofi investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Mid Growth
Sign-up for 500674 investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Core
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Core
  • Morningstar Rating: 4 Stars
Sign-up for sny investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Core
  • Morningstar Rating: 4 Stars
Sign-up for san investment picks

 
News Articles for Sanofi top ^
2013/3/7
Sanofi BioGENEius Challenge Canada celebrates 20 years of advancing science - 74% of SBCC participants pursued science careers thanks to national biotechnology research competition Canada NewsWire Now in its 20 th year, the "2013 Sanofi BioGENEius Challenge Canada (SBCC)" starts in mid-March and culminates in a national awards ceremony in Ottawa on April 9.
Sign-up for Sanofi BioGENEius Challenge Canada celebrates 20 years of advancing science - 74% of SBCC participants pursued science careers thanks to national biotechnology research competition investment picks
2013/3/6
Cambridge, Massachusetts Mayor Signs Proclamation Declaring March 6 Colorectal Cancer Awareness Day CAMBRIDGE, Mass.
Sign-up for Sanofi Oncology and Colon Cancer Coalition Join Forces to Raise Awareness of Colorectal Cancer investment picks
2013/3/2
Phase 1b Data Presented at Late Breaking Session of 71st Annual Meeting of the American Academy of Dermatology PARIS and TARRYTOWN, N.Y. , March 2, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that pooled data from two Phase 1b trials with dupilumab (REGN668/ SAR231893 ), an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting the alpha subunit of the interleukin 4 receptor (IL-4R alpha), were presented at the 71st Annual Meeting of the American Academy of Dermatology (AAD) in Miami .
Sign-up for Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis investment picks
2013/2/19
PARIS , Feb.
Sign-up for Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA investment picks
2013/1/30
http://media.marketwire.com/attachments/200501/200497_SciCloneLogo-Color-R.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979756&ProfileId=051205&sourceType=1 FOSTER CITY, CA --
Sign-up for SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China investment picks
2013/1/29
--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--
Sign-up for Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Sanofi
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Sanmina Corp  |  Next: ETFS Holding Sanofi Adr